6 months on topical Minoxidil + Finasteride Progress Pictures 7/31/2024
User has been using topical Minoxidil (5%) and Finasteride (0.1%) for 5-6 months, along with a dermaroller. No side effects reported, but user notes weight gain without change in diet or exercise.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Just 2 months on topical min and fin and It's growing all the way down my forehead
The user started using topical minoxidil and finasteride to address a receding hairline and has seen positive results without side effects. They apply 1ml of Morr F 5% drops nightly.
community How I Cut Hair Loss Treatment Costs by Sourcing from India — Where Do You Guys Buy From? (Indian Origin, US Resident)
The conversation discusses sourcing hair loss treatments from India to reduce costs. The treatments include Morr F Minoxidil + Finasteride solution, Traya Recap Hair Serum, a derma roller, and Man Matters DHT Blocking Shampoo and Conditioner.
community 2.5 months in (guess it’s time to grow it)
The user experienced significant hair growth using topical minoxidil 5%, finasteride 0.1%, and a 0.5 mm dermaroller weekly. They reported no side effects and are pleased with the results after 2.5 months.
community 4 month Min+Fin progress (topical)
A user shared their 4-month progress using a topical solution with 5% minoxidil and 0.1% finasteride, applied twice daily. They reported good results despite occasional missed applications.
community 6 months progress after minoxidil/finasteride stopped working
A 24-year-old with male pattern baldness experienced side effects from oral finasteride and switched to a topical minoxidil/finasteride combination, later incorporating daily shampooing and scalp brushing to manage hair loss and dandruff. After initial shedding, the regimen led to reduced hair loss and new hair growth, with the user now using a densita mf combination (5% minoxidil/0.1% finasteride + redensyl) nightly.
Related Research
6 / 6 results
research Efficacy and safety of combination therapy in androgenetic alopecia: Randomized uncontrolled evaluator blind study
This study found that combination therapy involving Minoxidil, Finasteride, or Saw palmetto with a dermaroller showed good to excellent results in male pattern baldness and moderate response in female pattern baldness over six months.
research Alopecia androgenética masculina: um relato de caso de tratamento com microagulhamento associado a fatores de crescimento e minoxidil tópico
This case report observed that a 44-year-old male patient with androgenetic alopecia experienced increased hair density and patient satisfaction after treatment with microneedling, growth factors, and minoxidil.
research Microneedling for the treatment of hair loss?
This review highlights that microneedling shows some promise for improving hair growth in alopecia, particularly when used with other treatments, though more research is needed to establish its efficacy and protocols.
research Female Androgenetic Alopecia: An Update on Diagnosis and Management
This review discusses female androgenetic alopecia, highlighting its diagnostic challenges and management strategies, but it reports no new results.
research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
research The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future
This study reviewed eight studies investigating transcutaneous drug delivery via fractional laser and microneedling for alopecia treatment, with six studies showing improved hair regrowth over topical therapy alone, suggesting its potential as a promising treatment strategy, although further research is needed to refine treatment parameters.